Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier.
cancer stem cells
genetic aberrations
molecular signatures
neuroblastoma
therapeutic targets
Journal
Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914
Informations de publication
Date de publication:
2019
2019
Historique:
received:
27
02
2019
accepted:
07
05
2019
entrez:
14
6
2019
pubmed:
14
6
2019
medline:
14
6
2019
Statut:
epublish
Résumé
Neuroblastoma (NB) is the most common extracranial solid tumor often diagnosed in childhood. Despite intense efforts to develop a successful treatment, current available therapies are still challenged by high rates of resistance, recurrence and progression, most notably in advanced cases and highly malignant tumors. Emerging evidence proposes that this might be due to a subpopulation of cancer stem cells (CSCs) or tumor-initiating cells (TICs) found in the bulk of the tumor. Therefore, the development of more targeted therapy is highly dependent on the identification of the molecular signatures and genetic aberrations characteristic to this subpopulation of cells. This review aims at providing an overview of the key molecular players involved in NB CSCs and focuses on the experimental evidence from NB cell lines, patient-derived xenografts and primary tumors. It also provides some novel approaches of targeting multiple drivers governing the stemness of CSCs to achieve better anti-tumor effects than the currently used therapeutic agents.
Identifiants
pubmed: 31191243
doi: 10.3389/fnmol.2019.00131
pmc: PMC6546065
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
131Références
Histol Histopathol. 2000 Jan;15(1):119-29
pubmed: 10668203
Med Pediatr Oncol. 2000 Dec;35(6):554-8
pubmed: 11107116
Cancer Res. 2001 May 1;61(9):3591-4
pubmed: 11325825
Nature. 2001 Nov 1;414(6859):105-11
pubmed: 11689955
Nat Rev Cancer. 2002 Jan;2(1):48-58
pubmed: 11902585
Pathology. 2003 Apr;35(2):125-9
pubmed: 12745459
Cancer Res. 2003 Sep 15;63(18):5821-8
pubmed: 14522905
Nature. 2003 Oct 30;425(6961):962-7
pubmed: 14574365
Nature. 2004 Jan 1;427(6969):78-83
pubmed: 14702088
J Biol Chem. 2004 Jul 2;279(27):27994-9
pubmed: 15117961
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14228-33
pubmed: 15381773
Neoplasia. 2004 Nov-Dec;6(6):838-45
pubmed: 15720811
Neurosci Res. 2005 May;52(1):75-82
pubmed: 15811555
Oncogene. 2006 Mar 23;25(13):1852-61
pubmed: 16288219
EMBO J. 2006 Jan 25;25(2):290-301
pubmed: 16407977
APMIS. 2005 Nov-Dec;113(11-12):922-9
pubmed: 16480458
Nucleic Acids Res. 2006 Mar 31;34(6):1745-54
pubmed: 16582100
Semin Cancer Biol. 2007 Jun;17(3):241-7
pubmed: 16839774
Cancer Cell. 2006 Nov;10(5):413-23
pubmed: 17097563
Cancer Res. 2007 Jan 15;67(2):735-45
pubmed: 17234785
Cancer Res. 2007 Mar 15;67(6):2402-7
pubmed: 17363556
Am J Pathol. 2007 Apr;170(4):1370-8
pubmed: 17392175
Cancer Res. 2007 Dec 1;67(23):11234-43
pubmed: 18056449
J Pathol. 2008 Jan;214(1):3-9
pubmed: 18067118
World J Pediatr. 2008 Feb;4(1):58-62
pubmed: 18402255
Stem Cells. 2008 Jul;26(7):1818-30
pubmed: 18467664
Cancer Res. 2008 Aug 1;68(15):6043-8
pubmed: 18676824
Nature. 2008 Oct 16;455(7215):930-5
pubmed: 18724359
Science. 2008 Oct 31;322(5902):756-60
pubmed: 18974357
G Ital Dermatol Venereol. 2009 Jun;144(3):287-96
pubmed: 19088701
Hum Genomics. 2009 Apr;3(3):281-90
pubmed: 19403462
Neoplasia. 2009 May;11(5):426-35
pubmed: 19412427
Pediatr Blood Cancer. 2010 Mar;54(3):361-8
pubmed: 19927294
Cancer Res. 2009 Dec 15;69(24):9271-80
pubmed: 19934310
Cancer Biol Ther. 2009 Dec;8(24):2386-95
pubmed: 19946221
Life Sci. 2010 Apr 24;86(17-18):631-7
pubmed: 20159023
J Histochem Cytochem. 2010 Aug;58(8):721-30
pubmed: 20421592
J Neurooncol. 2010 Dec;100(3):385-95
pubmed: 20467784
Radiat Oncol. 2010 Jul 19;5:66
pubmed: 20642823
Clin Cancer Res. 2010 Sep 15;16(18):4572-82
pubmed: 20651058
EMBO Mol Med. 2010 Sep;2(9):371-84
pubmed: 20721990
Oncogene. 2011 Jan 6;30(1):97-105
pubmed: 20818439
Nutr Res Pract. 2010 Aug;4(4):276-82
pubmed: 20827342
Nutr Cancer. 2010;62(7):919-30
pubmed: 20924967
J Biol Chem. 2011 Mar 18;286(11):9393-404
pubmed: 21135096
Clin Cancer Res. 2011 Jan 1;17(1):3-5
pubmed: 21208901
Clin Cancer Res. 2011 Jan 1;17(1):111-21
pubmed: 21208905
Curr Top Dev Biol. 2011;94:77-127
pubmed: 21295685
Biochim Biophys Acta. 2011 Jun;1813(6):1137-43
pubmed: 21296110
Cancer Res. 2011 Feb 15;71(4):1385-95
pubmed: 21303981
Tumour Biol. 2011 Aug;32(4):631-9
pubmed: 21340483
Cell Oncol (Dordr). 2011 Jun;34(3):189-97
pubmed: 21424816
Oncogene. 2011 Apr 7;30(14):1664-80
pubmed: 21472018
Int J Oncol. 2011 Oct;39(4):841-51
pubmed: 21701770
Environ Health Prev Med. 2012 May;17(3):246-51
pubmed: 21909813
Cancer Res. 2011 Nov 1;71(21):6899-908
pubmed: 21937684
Neoplasia. 2011 Oct;13(10):991-1004
pubmed: 22028624
Lab Invest. 2012 Mar;92(3):466-73
pubmed: 22083670
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):E225-33
pubmed: 22203997
Oncotarget. 2011 Dec;2(12):976-83
pubmed: 22249030
PLoS One. 2012;7(2):e30905
pubmed: 22363512
Curr Pharm Des. 2012;18(17):2464-71
pubmed: 22372504
Histopathology. 2012 Jun;60(7):1144-55
pubmed: 22394107
PLoS One. 2012;7(3):e33976
pubmed: 22470504
Genes Chromosomes Cancer. 2012 Aug;51(8):792-804
pubmed: 22514116
Pharmacol Rev. 2012 Jul;64(3):520-39
pubmed: 22544865
Nature. 2012 Apr 29;485(7397):195-200
pubmed: 22575959
Nat Med. 2012 Jun;18(6):892-901
pubmed: 22610277
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):8971-6
pubmed: 22615382
Oncogene. 2013 May 23;32(21):2640-8
pubmed: 22751132
Brain Pathol. 2013 Jan;23(1):60-72
pubmed: 22805276
Fetal Pediatr Pathol. 2013 Jun;32(3):192-204
pubmed: 22830353
Nutr Cancer. 2012 Aug;64(6):889-98
pubmed: 22860924
Cancer Res. 2012 Aug 15;72(16):4250-61
pubmed: 22871386
Tumour Biol. 2012 Dec;33(6):2173-83
pubmed: 22886526
Front Oncol. 2012 Aug 02;2:82
pubmed: 22891161
Oncogene. 2013 Aug 1;32(31):3616-26
pubmed: 22907436
Neurochem Int. 2012 Dec;61(7):1183-91
pubmed: 22948185
J Immunother. 2012 Oct;35(8):598-606
pubmed: 22996365
J Cell Biochem. 2013 Apr;114(4):854-63
pubmed: 23097134
J Pediatr Hematol Oncol. 2014 Jan;36(1):37-44
pubmed: 23128334
Mol Oncol. 2012 Dec;6(6):620-36
pubmed: 23141800
Clin Transl Med. 2013 Jan 17;2(1):3
pubmed: 23369605
Front Oncol. 2013 Jan 25;3:1
pubmed: 23373009
J Biol Chem. 2013 Mar 29;288(13):9408-17
pubmed: 23408432
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6097-102
pubmed: 23479628
Cancer Res. 2013 Jul 1;73(13):4134-46
pubmed: 23687340
Dev Neurobiol. 2013 Nov;73(11):815-27
pubmed: 23776185
Cell Death Dis. 2013 Jul 25;4:e740
pubmed: 23887631
Oncol Rep. 2013 Oct;30(4):1869-77
pubmed: 23900747
Food Chem Toxicol. 2013 Oct;60:520-9
pubmed: 23948355
PLoS One. 2013 Oct 07;8(10):e76761
pubmed: 24116151
Mol Cancer Res. 2014 Jan;12(1):155-64
pubmed: 24249679
Carcinogenesis. 2014 Apr;35(4):849-58
pubmed: 24282287
APMIS. 2014 Sep;122(9):734-41
pubmed: 24320714
J Immunother. 2014 Feb-Mar;37(2):93-104
pubmed: 24509172
Genes Dev. 2014 Feb 15;28(4):305-16
pubmed: 24532711
Oncogene. 2015 Feb 19;34(8):1019-34
pubmed: 24632619
Clin Transl Oncol. 2014 Jun;16(6):511-6
pubmed: 24647842
Arch Pharm (Weinheim). 2014 Jul;347(7):457-68
pubmed: 24677093
PLoS One. 2014 Apr 15;9(4):e94568
pubmed: 24736663
Int J Oncol. 2014 Jul;45(1):121-8
pubmed: 24789807
Int J Clin Pharmacol Ther. 2014 Sep;52(9):787-801
pubmed: 24902844
Biochem Biophys Res Commun. 2014 Aug 8;450(4):1475-80
pubmed: 25019987
Leuk Lymphoma. 2015 May;56(5):1406-15
pubmed: 25248882
Cell Death Dis. 2014 Oct 30;5:e1502
pubmed: 25356871
Cancer Res. 1989 Jan 1;49(1):219-25
pubmed: 2535691
Oncotarget. 2015 Jan 1;6(1):196-206
pubmed: 25415050
Oncology (Williston Park). 2014 Dec;28(12):1101-7, 1110
pubmed: 25510809
Int J Oncol. 2015 Mar;46(3):1089-98
pubmed: 25524880
Oncoscience. 2014 May 06;1(5):336-48
pubmed: 25594028
Oncotarget. 2015 Apr 20;6(11):8760-76
pubmed: 25797249
Cancer Res. 2015 Jun 15;75(12):2566-79
pubmed: 25908586
PLoS One. 2015 May 07;10(5):e0125343
pubmed: 25951238
J Pediatr Surg. 2015 Sep;50(9):1493-501
pubmed: 25976447
Sci Rep. 2015 Jun 09;5:11158
pubmed: 26057707
Stem Cells. 2015 Oct;33(10):2913-24
pubmed: 26086949
PLoS One. 2015 Jul 31;10(7):e0134111
pubmed: 26230845
Anal Cell Pathol (Amst). 2015;2015:150634
pubmed: 26258008
Stem Cell Res. 2015 Sep;15(2):419-26
pubmed: 26342562
Philos Trans R Soc Lond B Biol Sci. 2015 Oct 19;370(1680):20140376
pubmed: 26416685
Oncotarget. 2015 Oct 20;6(32):32821-40
pubmed: 26439802
BMB Rep. 2015 Dec;48(12):668-76
pubmed: 26497581
Blood. 2016 Jan 7;127(1):122-31
pubmed: 26531164
Front Neurosci. 2015 Nov 23;9:442
pubmed: 26635517
Sci Rep. 2015 Dec 17;5:18144
pubmed: 26674674
Front Cell Dev Biol. 2015 Dec 02;3:77
pubmed: 26697427
Cancers (Basel). 2015 Dec 31;8(1):null
pubmed: 26729169
PLoS One. 2016 Jan 13;11(1):e0146885
pubmed: 26761817
Mol Cancer. 2016 Feb 20;15:16
pubmed: 26897742
Cancer Invest. 2016;34(3):155-66
pubmed: 26963048
Cell Death Dis. 2016 Apr 21;7:e2202
pubmed: 27100896
Phytomedicine. 2016 Jun 15;23(7):736-44
pubmed: 27235712
Biochem Biophys Res Commun. 2016 Aug 19;477(2):255-9
pubmed: 27297102
Clin Cancer Res. 2017 Jan 15;23(2):466-477
pubmed: 27390347
Int J Oncol. 2016 Oct;49(4):1722-30
pubmed: 27432152
J Clin Invest. 2016 Oct 3;126(10):3814-3826
pubmed: 27571406
PLoS One. 2016 Sep 14;11(9):e0162916
pubmed: 27627801
Adv Exp Med Biol. 2016;928:245-265
pubmed: 27671820
BMC Cancer. 2016 Oct 10;16(1):781
pubmed: 27724856
Biochem Biophys Res Commun. 2016 Nov 11;480(2):254-260
pubmed: 27751853
Mol Neurobiol. 2017 Dec;54(10):7610-7619
pubmed: 27832522
Oncotarget. 2017 Jan 24;8(4):6730-6741
pubmed: 28036269
Biochem Biophys Res Commun. 2017 Feb 26;484(1):93-99
pubmed: 28104398
Mol Cancer. 2017 Feb 1;16(1):29
pubmed: 28148257
Sci Rep. 2017 Feb 08;7:41838
pubmed: 28176811
Genome Med. 2017 Feb 10;9(1):15
pubmed: 28187790
Anticancer Drugs. 2017 Jun;28(5):469-479
pubmed: 28240680
PLoS One. 2017 Apr 19;12(4):e0175953
pubmed: 28422997
PLoS One. 2017 May 3;12(5):e0176851
pubmed: 28467517
Oncotarget. 2017 May 9;8(19):32381
pubmed: 28499332
Acta Pharm Sin B. 2017 May;7(3):249-259
pubmed: 28540163
Clin Cancer Res. 2017 Nov 1;23(21):6629-6639
pubmed: 28821555
Mol Cancer. 2017 Aug 22;16(1):140
pubmed: 28830458
Cell Death Dis. 2017 Sep 7;8(9):e3039
pubmed: 28880275
Oncogene. 2018 Jan 18;37(3):286-301
pubmed: 28925404
Cell Tissue Res. 2018 May;372(2):269-275
pubmed: 29032465
Oncotarget. 2017 Nov 6;8(66):109985-109999
pubmed: 29299124
Int J Oncol. 2018 Mar;52(3):787-803
pubmed: 29328367
Med Sci Monit. 2018 Apr 18;24:2350-2359
pubmed: 29668670
Oncogene. 2018 Aug;37(33):4489-4504
pubmed: 29743588
BMC Cancer. 2018 May 11;18(1):560
pubmed: 29751783
Oncogene. 2018 Sep;37(39):5340-5354
pubmed: 29858603
Cancer Res. 1987 Mar 1;47(5):1383-9
pubmed: 3028608
Oncotarget. 2018 Sep 11;9(71):33549-33561
pubmed: 30323898
Stem Cells Transl Med. 2019 Jan;8(1):75-81
pubmed: 30328686
J Natl Cancer Inst. 1973 Mar;50(3):603-23
pubmed: 4513522
Cell Growth Differ. 1995 Apr;6(4):449-56
pubmed: 7794812
Virchows Arch. 1994;425(4):399-406
pubmed: 7820302
Blood. 1997 Dec 15;90(12):5002-12
pubmed: 9389720
Blood. 1997 Dec 15;90(12):5013-21
pubmed: 9389721
Oncogene. 1998 Jul 23;17(3):339-46
pubmed: 9690515